These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19487041)

  • 1. Utilization of health technologies-Do not look where there is a light; shine your light where there is a need to look! Relating national health goals with resource allocation decision-making; illustration through examining the Israeli healthcare system.
    Shavit O
    Health Policy; 2009 Oct; 92(2-3):268-75. PubMed ID: 19487041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of medical technologies.
    Seifan A; Shemer J
    Isr Med Assoc J; 2005 Feb; 7(2):67-70. PubMed ID: 15729952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?
    Greenberg D; Siebzehner MI; Pliskin JS
    Int J Technol Assess Health Care; 2009 Jul; 25(3):255-61. PubMed ID: 19619343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public healthcare resource allocation and the Rule of Rescue.
    Cookson R; McCabe C; Tsuchiya A
    J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology management: case study of an integrated health system.
    Dahl DH; McFarlan TK
    Hosp Technol Ser; 1994 Dec; 13(17):1-30. PubMed ID: 10139509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparing a business justification for going electronic.
    Ortiz AO; Luyckx MP
    Radiol Manage; 2002; 24(1):14-21. PubMed ID: 11857990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
    Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
    Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems.
    Douw K; Vondeling H
    Int J Technol Assess Health Care; 2006; 22(2):177-83. PubMed ID: 16571193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making tough resource decisions. A process for considering both values and costs.
    Boyle PJ; Moskowitz E
    Health Prog; 1996; 77(6):48-53. PubMed ID: 10163236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and regulation of health care technology. The Dutch experience.
    Boer A
    Int J Technol Assess Health Care; 1999; 15(4):638-48. PubMed ID: 10645105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.